{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,3,12]],"date-time":"2023-03-12T05:39:32Z","timestamp":1678599572397},"reference-count":8,"publisher":"The Japan Geriatrics Society","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nippon Ronen Igakkai Zasshi","Nihon Ronen Igakkai Zasshi","Jpn J Geriat","Jpn. j. geriat"],"published-print":{"date-parts":[[2023,1,25]]},"DOI":"10.3143\/geriatrics.60.25","type":"journal-article","created":{"date-parts":[[2023,3,7]],"date-time":"2023-03-07T22:10:40Z","timestamp":1678227040000},"page":"25-32","source":"Crossref","is-referenced-by-count":0,"title":["Voiding dysfunction in geriatric people"],"prefix":"10.3143","volume":"60","author":[{"given":"\u6804\u4e00\u90ce","family":"\u9ad8\u5ca1","sequence":"first","affiliation":[{"name":"\u81ea\u6cbb\u533b\u79d1\u5927\u5b66\u533b\u5b66\u90e8\u814e\u6ccc\u5c3f\u5668\u5916\u79d1\u5b66\u8b1b\u5ea7"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u54f2\u4e5f","family":"\u85e4\u6751","sequence":"additional","affiliation":[{"name":"\u81ea\u6cbb\u533b\u79d1\u5927\u5b66\u533b\u5b66\u90e8\u814e\u6ccc\u5c3f\u5668\u5916\u79d1\u5b66\u8b1b\u5ea7"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1704","reference":[{"key":"1","unstructured":"1) \u672c\u9593\u4e4b\u592b, \u67ff\u5d0e\u79c0\u5b8f, \u5f8c\u85e4\u767e\u4e07, \u6b66\u4e95\u5b9f\u6839\u96c4, \u5c71\u897f\u53cb\u5178, \u6797 \u90a6\u5f66; \u6392\u5c3f\u306b\u95a2\u3059\u308b\u75ab\u5b66\u7684\u7814\u7a76\u59d4\u54e1\u4f1a: \u6392\u5c3f\u306b\u95a2\u3059\u308b\u75ab\u5b66\u7684\u7814\u7a76. \u65e5\u6392\u5c3f\u6a5f\u80fd\u4f1a\u8a8c 2003; 14: 266-277."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Filson CP, Hollingsworth JM, Clemens JQ, Wei JT: The efficacy and safety of combined therapy with \u03b1-blockers and anticholinergics for men with benign prostatic hyperplasia: a meta-analysis. J Urol 2013; 190: 2153-2160.","DOI":"10.1016\/j.juro.2013.05.058"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Kakizaki H, Lee KS, Yamamoto O, Jong JJ, Katou D, Sumarsono B, et al.: Mirabegron Add-on Therapy to Tamsulosin for the Treatment of Overactive Bladder in Men with Lower Urinary Tract Symptoms: A Randomized, Placebo-controlled Study (MATCH). Eur Urol Focus 2020; 6: 729-737.","DOI":"10.1016\/j.euf.2019.10.019"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Yamanishi T, Kaga K, Sakata K, Yokoyama T, Kageyama S, Fuse M, et al.: A randomized controlled study of the efficacy of tadalafil monotherapy versus combination of tadalafil and mirabegron for the treatment of persistent overactive bladder symptoms in men presenting with lower urinary tract symptoms (CONTACT Study). Neurourol Urodyn 2020; 39: 804-812.","DOI":"10.1002\/nau.24285"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Kallidonis P, Adamou C, Kotsiris D, Ntasiotis P, Verze P, Athanasopoulos A: Young Academic Urologists of the European Association of Urology-Endourology Working Party: Combination Therapy with Alpha-blocker and Phosphodiesterase-5 Inhibitor for Improving Lower Urinary Tract Symptoms and Erectile Dysfunction in Comparison with Monotherapy: A Systematic Review and Meta-analysis. Eur Urol Focus 2020; 15: 537-558.","DOI":"10.1016\/j.euf.2019.05.007"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Kelleher C, Hakimi Z, Zur R, Siddiqui E, Maman K, Aball\u00e9a S, et al.: Efficacy and Tolerability of Mirabegron Compared with Antimuscarinic Monotherapy or Combination Therapies for Overactive Bladder: A Systematic Review and Network Meta-analysis. Eur Urol 2018; 74: 324-333.","DOI":"10.1016\/j.eururo.2018.03.020"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Suskind AM, Quanstrom K, Zhao S, Bridge M, Walter LC, Neuhaus J, et al.: Overactive Bladder Is Strongly Associated With Frailty in Older Individuals. Urology 2017; 106: 26-31.","DOI":"10.1016\/j.urology.2017.03.058"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Offermans MP, Du Moulin MF, Hamers JP, Dassen T, Halfens RJ: Prevalence of urinary incontinence and associated risk factors in nursing home residents: a systematic review. Neurourol Urodyn 2009; 28: 288-294.","DOI":"10.1002\/nau.20668"}],"container-title":["Nippon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/geriatrics\/60\/1\/60_60.25\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,11]],"date-time":"2023-03-11T04:23:59Z","timestamp":1678508639000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/geriatrics\/60\/1\/60_60.25\/_article\/-char\/ja\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,25]]},"references-count":8,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.3143\/geriatrics.60.25","relation":{},"ISSN":["0300-9173"],"issn-type":[{"value":"0300-9173","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1,25]]},"article-number":"60.25"}}